The UK company has developed a large portfolio and catalogue of Research Use Only (RUO) antibodies, proteins, small molecules and ELISA kits for proteomic applications across a broad range of key biological research areas including cancer, stem cells, neuroscience and immunology. The company supplies both the academic and industry life science & biotech markets through both B2C and B2B channels. The company is continually looking to expand its existing portfolio of products and services by partnering and inward licensing with academic and research partners.
The company offers partners the benefits of a major, recognisable brand name under which products are sold worldwide through a well established distributor network. It also offers in-house expertise for the development of in-licensed new products and services into ELISA kits and derivative products such as antibody conjugates, providing greater opportunities to generate revenue.
The company is seeking researchers and/or developers to license in new products that the company would develop to be market-ready.
Manufacturers of described products are sought to manufacture them and supply for selling from the UK, under manufacturing agreements.